![](https://investorshub.advfn.com/uicon/781877.png?cb=1671015813)
Thursday, August 03, 2023 6:10:38 PM
Below is what Max said from a shareholder letter on 12/30/2022 concerning upcoming dilution. They had to move the offering to .00025 in February due to low SP and not being able to sell the offering at .0004.
How do we finance our revenue rollout plan for 2023? On December 21, 2022 we received
qualification from the SEC to our new Regulation A public offering to raise up to $1 million in
new capital through the issuance of our common stock at $ 0.0004 per share. The duration of
the approved offering is 12 months. These funds will cover both future product sample and
certification costs, advertising and promotion, product manufacturing, sales and distribution and
corporate operating costs into 2023. This will keep us funded to enable us to achieve our 2023
goals.
And this is the use of proceeds from the updated 1-a at .00025
![](http://cdn.discordapp.com/attachments/920631267865817129/1136785600490508338/image.png)
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM